| Literature DB >> 22235868 |
Juliane Günther1, Wolfram Petzl, Holm Zerbe, Hans-Joachim Schuberth, Dirk Koczan, Leopold Goetze, Hans-Martin Seyfert.
Abstract
BACKGROUND: Udder infections with environmental pathogens like Escherichia coli are a serious problem for the dairy industry. Reduction of incidence and severity of mastitis is desirable and mild priming of the immune system either through vaccination or with low doses of immune stimulants such as lipopolysaccharide LPS was previously found to dampen detrimental effects of a subsequent infection. Monocytes/macrophages are known to develop tolerance towards the endotoxin LPS (endotoxin tolerance, ET) as adaptation strategy to prevent exuberant inflammation.We have recently observed that infusion of 1 μg of LPS into the quarter of an udder effectively protected for several days against an experimentally elicited mastitis. We have modelled this process in primary cultures of mammary epithelial cells (MEC) from the cow. MEC are by far the most abundant cells in the healthy udder coming into contact with invading pathogens and little is known about their role in establishing ET.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22235868 PMCID: PMC3315725 DOI: 10.1186/1471-2164-13-17
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Schematic diagram of the experimental setting.
Figure 2Dendrogram clustering the data from the individual experimental cultures, using centred correlation and average linkage. Numbers indicate pbMEC preparations obtained from the three different cows. The dendrogram is based on all data as obtained after the GCRMA normalization. Note that the data are clustering according to treatment rather than the individuals from which the pbMEC cultures have been established.
Total numbers of significantly differentially expressed transcripts (DET) and genes (DEG) comparing LPS-primed (P.) vs. unstimulated pbMEC (C.) and E. coli challenged primed (I.p.P.) vs. E. coli challenged naïve cells (I.)
| Short waiting period | Long waiting period | |||||||
|---|---|---|---|---|---|---|---|---|
| DET | ||||||||
| ↑ 37 | ↓ 11 | ↑ 45 | ↓ 272 | ↑ 11 | ↓ 4 | ↑ 2 | ↓ 4 | |
| IPA mapped DEG | ||||||||
| ↑ 30 | ↓ 10 | ↑ 38 | ↓ 188 | ↑ 9 | ↓ 4 | ↑ 2 | ↓ 4 | |
Top ten DEG after short waiting period comparing LPS-primed (P.) versus unstimulated control cells (C.)
| Symbol | Entrez Gene Name | Mean ratio | Expression regulated by* | |||
|---|---|---|---|---|---|---|
| IL1 | TNF | IL6 | IRF7 | |||
| CCL5 | chemokine (C-C motif) ligand 5 | x | x | x | x | |
| SAA3 | serum amyloid A3 | x | ||||
| FAM14A | family with sequence similarity 14, member A | |||||
| HP | haptoglobin | x | x | x | ||
| RTP4 | receptor (chemosensory) transporter protein 4 | |||||
| PARM1 | prostate androgen-regulated mucin-like protein 1 | |||||
| CFB | complement factor B | x | ||||
| PLAC8 | placenta-specific 8 | |||||
| HLA-DRA | major histocompatibility complex, class II, DR alpha | x | ||||
| MUC1 | mucin 1, cell surface associated | x | x | |||
| ELTD1 | EGF, latrophilin and seven transmembrane domain containing 1 | |||||
| TRIB3 | tribbles homolog 3 | |||||
| TBXAS1 | thromboxane A synthase 1 | |||||
| RASSF4 | Ras association domain family 4 | |||||
| PYCR1 | pyrroline-5-carboxylate reductase 1 | |||||
| G0S2 | putative lymphocyte G0/G1 switch gene | x | x | |||
| FUT1 | fucosyltransferase 1 | |||||
| C1orf24 | chromosome 1 open reading frame 24 | |||||
| PCTP | phosphatidylcholine transfer protein | |||||
| PSAT1 | phosphoserine aminotransferase 1 | |||||
* Expression of the respective gene is known to be regulated by IL1, TNF, IL6, and/or IRF7 (based on Ingenuity Knowledge Database).
Figure 3Overview of differentially expressed genes in primed and challenged pbMEC (I.p.P.) compared to naïve cells challenged with the same . A: Hierarchical clustering of the 226 DEGs comparing primed and challenged cells to naïve challenged pbMEC. The heat map represents the expression level of each DEG in the three different pbMEC preparations (1, 2, 3) as determined in the three challenge groups (I.p.P., I., and P.). Data were sorted according to the extent of the differential expression between I.p.P. vs. I. The heatmap is based on the log(2) fold changes between the 3 treatment groups relative to the respective un-stimulated control cells (Additional file 2, Table S2A). The rows of the matrix were normalized to have the values 0 as a mean, and 1 as associated variance. Red indicates high and green low expression. B: IPA network analysis of the regulatory relationship of DEGs between the treatment groups I.p.P. (induction post priming) vs I. (challenge of naïve cells). Red, higher expression in I.p.P.; green, lower expression in I.p.P. IL-1B is known to regulate the expression of 44 genes (red arrows). The transcription factor IRF7 is known to regulate the expression of 34 genes (blue arrows).
Priming-related modulation of gene expression subsequent to an E. coli challenge after a short waiting period
| Symbol | Entrez Gene Name | Mean ratio | Mean ratio compared to | Expression regulated by**** | |||||
|---|---|---|---|---|---|---|---|---|---|
| I.p.P./C. | I./C. | P./C. | IL1 | TNF | IL6 | IRF7 | |||
| | coronin, actin binding protein, 1A | ||||||||
| | CD55 molecule, decay accelerating factor for complement | x | x | ||||||
| | major histocompatibility complex, class II, DQ alpha 1 | x | |||||||
| TGM3 | transglutaminase 3 | ||||||||
| | secretory leukocyte peptidase inhibitor | x | |||||||
| LY6G6E | lymphocyte antigen 6 complex, locus G6E | NC | |||||||
| CYP26A1 | cytochrome P450, family 26, subfamily A, polypeptide 1 | NC | |||||||
| | defensin, beta 4A | x | x | ||||||
| | major histocompatibility complex, class II, DR alpha | x | |||||||
| ATP6V0A4 | ATPase, H+ transporting, lysosomal V0 subunit a4 | NC | NC | ||||||
| | nitric oxide synthase 2, inducible | NC | x | x | x | ||||
| | guanylate binding protein 2, interferon-inducible | x | x | x | |||||
| APOL3 | apolipoprotein L, 3 | NC | |||||||
| | interleukin 1, beta | NC | x | x | |||||
| TIFA | TRAF-interacting protein with forkhead-associated domain | NC | |||||||
| | tumor necrosis factor (ligand) superfamily, member 13b | NC | x | x | |||||
| TMEM140 | transmembrane protein 140 | NC | |||||||
| | guanylate binding protein 4 | NC | NC | x | x | ||||
| LMO2 | LIM domain only 2 (rhombotin-like 1) | NC | NC | ||||||
| | receptor (chemosensory) transporter protein 4 | x | |||||||
* bold letters, part of a network connected by the IPA relationship "Expression" (Fig 3B)
** bold numbers, fc > 1.5, p < 0.005
*** italic number, fc > 1.5, p > 0.005
NC, No change fc < 1.5
**** Expression of the respective gene is known to be regulated by IL1, TNF, IL6, and/or IRF7 (based on Ingenuity Knowledge Database).
Figure 4Quantification of the expression of selected genes by RT-qPCR. Ordinate, relative copy number (n, 3 each; ± S.E.M.) determined in the short time waiting experiment. Open bars: unstimulated control, filled bars: primed cells, light sanded bars: E. coli induction of naïve cells; dark shaded bars: E. coli induction of primed cells. Fold changes and significance (* p < 0.1, ** p < 0.05, *** p < 0.01, paired t-test) of the priming-related differential expression are indicated. All individual data are listed in the Additional file 4, Table S4.